You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radioimmunotherapy

Showing 1 - 25 of 186
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Nantes (Antibody TF2, 90-Y-IMP-288, 111-In-IMP-288)

Terminated
  • Metastatic Colorectal Cancer
  • Antibody TF2
  • +2 more
  • Nantes, France
    CHU de Nantes
Jul 29, 2022

Pancreatic Carcinoma, Tumors That Express CA 19-9 Trial in Scottsdale, New York (MVT-1075, MVT-5873)

Suspended
  • Pancreatic Carcinoma
  • Tumors That Express CA 19-9
  • Scottsdale, Arizona
  • +1 more
Aug 23, 2022

Medulloblastoma, Childhood Trial in Worldwide (177Lu-DTPA-omburtamab)

Terminated
  • Medulloblastoma, Childhood
  • Rochester, Minnesota
  • +9 more
Aug 15, 2022

Leptomeningeal Metastasis, Solid Tumor, Adult Trial in United Kingdom, United States (radiolabeled DPTA-omburtamab)

Withdrawn
  • Leptomeningeal Metastasis
  • Solid Tumor, Adult
  • radiolabeled DPTA-omburtamab
  • Los Angeles, California
  • +7 more
Jul 12, 2022

Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

Active, not recruiting
  • Mantle Cell Lymphoma
  • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
  • Basking Ridge, New Jersey
  • +4 more
Dec 1, 2022

Peritoneal Cancer Trial in New York (131 I-8H9)

Active, not recruiting
  • Peritoneal Cancer
  • 131 I-8H9
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 7, 2022

SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • SCLC
  • +2 more
  • GD2-SADA:177Lu-DOTA Complex
  • (no location specified)
May 4, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Actinium Ac 225-DOTA-Daratumumab, Daratumumab,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Actinium Ac 225-DOTA-Daratumumab
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)

Available
  • Central Nervous System/Leptomeningeal Neoplasms
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 15, 2022

Prostate Cancer Trial in New York (117Lu-J591)

Completed
  • Prostate Cancer
  • New York, New York
    Weill Cornell Medical College-New York Presbyterian Hospital
Mar 16, 2021

Neuroblastoma, CNS Metastases, Leptomeningeal Metastases Trial in Worldwide (131I-omburtamab)

Recruiting
  • Neuroblastoma
  • +2 more
  • 131I-omburtamab
  • Los Angeles, California
  • +11 more
Dec 17, 2021

Non-Hodgkin's Lymphoma, Lymphoma, B-Cell Trial (radiolabeled epratuzumab)

Completed
  • Non-Hodgkin's Lymphoma
  • Lymphoma, B-Cell
  • radiolabeled epratuzumab
  • (no location specified)
Aug 12, 2021

Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

Recruiting
  • Plasma Cell Myeloma
  • Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 27, 2022

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
Has Results
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Metastatic Colorectal Cancer Trial in Washington (TF2/IMP288)

Withdrawn
  • Metastatic Colorectal Cancer
  • Washington, District of Columbia
    Georgetown University Medical Center
Aug 12, 2021

Acute Myeloblastic Leukemia, Acute Lymphoblastic Leukemia, Juvenile Myelomonocytic Leukemia Trial in London (Yttrium-90 labelled

Completed
  • Acute Myeloblastic Leukemia
  • +2 more
  • Yttrium-90 labelled monoclonal antibody against CD66
  • London, United Kingdom
    Great Ormond Street Hospital for Children
Jun 24, 2021

Pancreatic Tumors Trial in Worldwide (hMN14 (labetuzumab))

Completed
  • Pancreatic Neoplasms
  • hMN14 (labetuzumab)
  • Newport Beach, California
  • +9 more
Aug 12, 2021

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Nashville (procedure, drug, other, biological, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 11, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Brain and CNS Tumors Trial in New York (drug, procedure, radiation)

Completed
Has Results
  • Brain and Central Nervous System Tumors
  • New York, New York
  • +1 more
Apr 28, 2020

Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Worldwide (hMN14 (labetuzumab))

Completed
  • Colorectal Cancer
  • +5 more
  • hMN14 (labetuzumab)
  • Newport Beach, California
  • +9 more
Aug 12, 2021

Non-hodgkin Lymphoma Trial (CD38-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • CD38-SADA:177Lu-DOTA Complex
  • (no location specified)
Aug 15, 2023

Squamous Cell Carcinoma of Larynx Trial in São Paulo (carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v.

Recruiting
  • Squamous Cell Carcinoma of Larynx
  • carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v. on day 1, every 21 days for 3 cycles
  • +2 more
  • São Paulo, Brazil
    Beneficiencia Portuguesa de São Paulo/Hospital São José
Dec 22, 2022

Relapsed Follicular Lymphoma Trial in Italy (ZEVALIN, BEAM)

Active, not recruiting
  • Relapsed Follicular Lymphoma
  • Genova, GE, Italy
  • +37 more
Dec 22, 2022

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting
  • Ann Arbor Stage I Grade 1 Follicular Lymphoma
  • +9 more
  • Quality-of-Life Assessment
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 3, 2022